CRDL
NASDAQ · Pharmaceuticals
Cardiol Therapeutics Inc-A
$1.00
+0.07 (+7.39%)
Open$0.97
Previous Close$0.93
Day High$1.00
Day Low$0.94
52W High$3.23
52W Low$1.23
Volume—
Avg Volume102.4K
Market Cap173.75M
P/E Ratio—
EPS$-0.34
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,340.2% upside
Current
$1.00
$1.00
Target
$24.28
$24.28
$16.80
$24.28 avg
$33.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.47M | 20.00M | 18.14M |
| Net Income | 5.10M | 5.20M | 4.96M |
| Profit Margin | 23.8% | 26.0% | 27.3% |
| EBITDA | 10.24M | 10.30M | 9.42M |
| Free Cash Flow | 5.58M | 6.38M | 6.16M |
| Rev Growth | +3.9% | -4.2% | -9.3% |
| Debt/Equity | 1.16 | 1.28 | 1.00 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |